Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial in Korean patients with seasonal allergic rhinitis evaluating safety, tolerability, and efficacy of bilastine 20 mg. The study…
-
FDA approval · 2014-06-12FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) submitted by Chattem, Inc.
-
FDA approval · 2014-06-02FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) by Viatris Specialty LLC. The appr…
-
CLINICAL_TRIALS research · 2014-05-30Clinical Trial Update: StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study [Phase 2]
Phase 2, five-arm, parallel-group, double-blind study evaluating StahistRx for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519) [Phase 3]
Phase 3 trial results for MK-0476 in Japanese pediatric participants with seasonal allergic rhinitis, reporting efficacy and safety data and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis [Phase 2]
Phase 2 study evaluating the efficacy and safety of gpASIT+TM for seasonal allergic rhinitis caused by grass pollen has been completed.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis [Phase 1]
Phase 1 safety and tolerability study of Grass Pollen-derived Peptides for seasonal allergic rhinitis has completed, focusing on safety and …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season [Phase 2]
A Phase 2 randomized crossover trial evaluated the safety and efficacy of three oral doses of BI 671800 versus fluticasone propionate and mo…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) [Phase 3]
A Phase 3 safety and efficacy study of ciclesonide nasal aerosol in children 6-11 with seasonal allergic rhinitis completed, with results po…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever [EARLY_Phase 1]
This document reports the completion of an early-phase 1 trial evaluating a topical nasal spray for seasonal allergic rhinitis, with results…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluating a nasal spray of resveratrol for seasonal allergic rhinitis in children has been completed.
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis [Phase 2]
Phase II clinical trial evaluating the combination of ONO-4053 and cetirizine for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers [Phase 1]
Phase 1 trial comparing mometasone nasal spray, Nasonex nasal spray, Nasonex nasal spray suspension, and placebo in 1,520 adults to evaluate…
-
FDA approval · 2014-04-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, granting generic approval under ANDA 20…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Assessment of Fluticasone Propionate on Ocular Allergy Symptoms [Phase 3]
A Phase 3 clinical trial evaluated fluticasone propionate for ocular allergy symptoms in allergic rhinitis patients; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects [Phase 2]
A Phase 2 clinical trial of STAHIST for Seasonal Allergic Rhinitis has completed.
-
CLINICAL_TRIALS withdrawal · 2014-03-06Clinical Trial Update: Study of AHIST in Seasonal Allergic Rhinitis Patients [Phase 1]
A Phase 1 clinical trial evaluating AHIST for seasonal allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS research · 2014-02-19Clinical Trial Update: Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC) [NA]
A completed, single-centre 6-period clinical trial in seasonal allergic rhinitis to establish a birch pollen challenge model using an enviro…
-
FDA approval · 2014-01-31FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., resulting in labelin…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating a subcutaneous immunotherapy treatment for grass pollen–induce…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis? [NA]
A completed study explored whether a nasal decongestant response can predict treatment outcomes in seasonal allergic rhinitis. The results w…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects [Phase 3]
A Phase 3 study evaluated the efficacy of levocetirizine and cetirizine in reducing symptoms of seasonal allergic rhinitis in ragweed-sensit…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen [Phase 3]
A Phase 3 head-to-head trial comparing levocetirizine with montelukast for reducing seasonal allergic rhinitis symptoms in ragweed-pollen–ex…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 randomized trial comparing levocetirizine with loratadine for the treatment of seasonal allergic rhinitis to evaluate efficacy and s…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) [Phase 4]
Phase 4 trial update for the POPULAR study evaluating patient preference using levocetirizine in seasonal allergic rhinitis; study status is…